HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >

Sort by: In order: Results/Page Authors/Record:
Export metadata:
Showing results 1 to 10 of 10
TypeAuthor(s)TitleOther TitlesCitationCitation(alt)Issue Date
articleSho, Takuya; Suda, Goki; Yamamoto, Yoshiya; Furuya, Ken; Baba, Masaru; Ogawa, Koji; Kubo, Akinori; Tokuchi, Yoshimasa; Fu, Qingjie; Yang, Zijian; Kimura, Megumi; Kitagataya, Takashi; Maehara, Osamu; Ohnishi, Shunsuke; Nakamura, Akihisa; Yamada, Ren; Ohara, Masatsugu; Kawagishi, Naoki; Natsuizaka, Mitsuteru; Nakai, Masato; Suzuki, Kazuharu; Izumi, Takaaki; Meguro, Takashi; Terashita, Katsumi; Takagi, Tomofumi; Ito, Jun; Kobayashi, Tomoe; Miyagishima, Takuto; Sakamoto, NaoyaEfficacy and Effect on Liver Functional Reserve of Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma in Patients Who Do Not Meet Eligibility Criteria of IMbrave150-Cancers-15-Aug-2022
articleTakimoto-Sato, Michiko; Miyauchi, Toshinari; Suzuki, Masaru; Ujiie, Hideyuki; Nomura, Toshifumi; Ikari, Tomoo; Nakamura, Tomohiko; Takahashi, Kei; Matsumoto-Sasaki, Machiko; Kimura, Hirokazu; Kimura, Hiroki; Matsui, Yuichiro; Kitagataya, Takashi; Yamada, Ren; Suzuki, Kazuharu; Nakamura, Akihisa; Nakai, Masato; Sho, Takuya; Ogawa, Koji; Sakamoto, Naoya; Yamaguchi, Naoko; Otsuka, Noriyuki; Tomaru, Utano; Konno, SatoshiCase Report : Hereditary Fibrosing Poikiloderma With Tendon Contractures, Myopathy, and Pulmonary Fibrosis (POIKTMP) Presenting With Liver Cirrhosis and Steroid-Responsive Interstitial Pneumonia-Frontiers in Genetics-May-2022
articleNakai, Masato; Yamamoto, Yoshiya; Baba, Masaru; Suda, Goki; Kubo, Akinori; Tokuchi, Yoshimasa; Kitagataya, Takashi; Yamada, Ren; Shigesawa, Taku; Suzuki, Kazuharu; Nakamura, Akihisa; Sho, Takuya; Morikawa, Kenichi; Ogawa, Koji; Furuya, Ken; Sakamoto, NaoyaPrediction of hepatocellular carcinoma using age and liver stiffness on transient elastography after hepatitis C virus eradication-Scientific reports-27-Jan-2022
article (author version)Kitagataya, Takashi; Suda, Goki; Nagashima, Kazunori; Katsurada, Takehiko; Yamamoto, Koji; Kimura, Megumi; Maehara, Osamu; Yamada, Ren; Shigesawa, Taku; Suzuki, Kazuharu; Nakamura, Akihisa; Ohara, Masatsugu; Umemura, Machiko; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Ohnishi, Shunsuke; Komatsu, Yoshito; Hata, Hiroo; Takeuchi, Satoshi; Abe, Takashige; Sakakibara-Konishi, Jun; Teshima, Takanori; Homma, Akihiro; Sakamoto, NaoyaPrevalence, clinical course, and predictive factors of immune checkpoint inhibitor monotherapy-associated hepatitis in Japan-Journal of gastroenterology and hepatology-Oct-2020
articleShigesawa, Taku; Suda, Goki; Kimura, Megumi; Shimazaki, Tomoe; Maehara, Osamu; Yamada, Ren; Kitagataya, Takashi; Suzuki, Kazuharu; Nakamura, Akihisa; Ohara, Masatsugu; Umemura, Machiko; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Sakamoto, NaoyaBaseline angiopoietin-2 and FGF19 levels predict treatment response in patients receiving multikinase inhibitors for hepatocellular carcinoma-JGH open-Oct-2020
articleSho, Takuya; Suda, Goki; Ogawa, Koji; Kimura, Megumi; Shimazaki, Tomoe; Maehara, Osamu; Shigesawa, Taku; Suzuki, Kazuharu; Nakamura, Akihisa; Ohara, Masatsugu; Umemura, Machiko; Kawagishi, Naoki; Natsuizaka, Mitsuteru; Nakai, Masato; Morikawa, Kenichi; Furuya, Ken; Baba, Masaru; Yamamoto, Yoshiya; Kobayashi, Tomoe; Meguro, Takashi; Saga, Akiyoshi; Miyagishima, Takuto; Yokoo, Hideki; Kamiyama, Toshiya; Taketomi, Akinobu; Sakamoto, NaoyaEarly response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real-world setting-JGH open-Feb-2020
articleOgawa, Koji; Kobayashi, Takashi; Furukawa, Jun-ichi; Hanamatsu, Hisatoshi; Nakamura, Akihisa; Suzuki, Kazuharu; Kawagishi, Naoki; Ohara, Masatsugu; Umemura, Machiko; Nakai, Masato; Sho, Takuya; Suda, Goki; Morikawa, Kenichi; Baba, Masaru; Furuya, Ken; Terashita, Katsumi; Kobayashi, Tomoe; Onodera, Manabu; Horimoto, Takahiro; Shinada, Keisuke; Tsunematsu, Seiji; Tsunematsu, Izumi; Meguro, Takashi; Mitsuhashi, Tomoko; Hato, Megumi; Higashino, Kenichi; Shinohara, Yasuro; Sakamoto, NaoyaTri-antennary tri-sialylated mono-fucosylated glycan of alpha-1 antitrypsin as a non-invasive biomarker for non-alcoholic steatohepatitis : a novel glycobiomarker for non-alcoholic steatohepatitis-Scientific reports-15-Jan-2020
articleSuda, Goki; Nakai, Masato; Sho, Takuya; Kimura, Megumi; Shimazaki, Tomoe; Maehara, Osamu; Shigesawa, Taku; Suzuki, Kazuharu; Nakamura, Akihisa; Ohara, Masatsugu; Umemura, Machiko; Kawagishi, Naoki; Baba, Masaru; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Sakamoto, NaoyaThe Successful Retreatment with Glecaprevir and Pibrentasvir of Genotype 1 or 2 HCV-infected Hemodialysis Patients who Failed to Respond to NS5A and Protease Inhibitor Treatment-Internal medicine-1-Apr-2019
articleOhara, Masatsugu; Ogawa, Koji; Suda, Goki; Kimura, Megumi; Maehara, Osamu; Shimazaki, Tomoe; Suzuki, Kazuharu; Nakamura, Akihisa; Umemura, Machiko; Izumi, Takaaki; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ohnishi, Shunsuke; Sakamoto, NaoyaL-Carnitine Suppresses Loss of Skeletal Muscle Mass in Patients With Liver Cirrhosis-Hepatology communications-Aug-2018
articleKawagishi, Naoki; Suda, Goki; Nakamura, Akinobu; Kimura, Megumi; Maehara, Osamu; Suzuki, Kazuharu; Nakamura, Akihisa; Ohara, Masatsugu; Izumi, Takaaki; Umemura, Machiko; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Kudo, Yusuke; Nishida, Mutsumi; Miyoshi, Hideaki; Sakamoto, NaoyaLiver steatosis and dyslipidemia after HCV eradication by direct acting antiviral agents are synergistic risks of atherosclerosis-PLOS ONE-2018
Showing results 1 to 10 of 10

 

Hokkaido University